Esch, B.E., & Carr, J.E. (2004). Secretin as a treatment for autism: A review of the evidence. Journal of Autism and Developmental Disorders, 34(5), 543-556. doi: 10.1007/s10803-004-2549-6.
Horvath, K., Stefanotos, G., Sokolski, K.N., Watchel, R., Nabros, L., & Tildon, J.T. (1998). Improved social and language skills after secretin administration in patients with autistic spectrum disorder. Pediatrics, 135, 559-563.
National Autism Center (2015). Findings and conclusions: National standards project, phase 2. Randolph, MA: National Autism Center. Retrieved 26 September 2016 from http://www.nationalautismcenter.org/national-standards-project/results-reports/.
National Institute for Health and Care Excellence (NICE) (2016). Autism in under 19s: Support and management. NICE: London. Retrieved 1 July 2016 from www.nice.org.uk/guidance/CG170/chapter/1-Recommendations.
Prior, M., & Roberts, J. (2012). Early intervention for children with autism spectrum disorders: Guidelines for good practice. Canberra: Australian Government Department of Social Services. Retrieved 23 June 2016 from https://www.dss.gov.au/our-responsibilities/disability-and-carers/program-services/for-people-with-disability/early-intervention-for-children-with-autism-spectrum-disorders-guidelines-for-good-practice-2012.
Prior, M., Roberts, J.M., Rodger, S., Williams, K., & Sutherland, R. (2011). A review of the research to identify the most effective models of practice in early intervention for children with autism spectrum disorders. Canberra: Australian Government Department of Families, Housing, Community Services and Indigenous Affairs. Retrieved 26 September 2016 from https://www.dss.gov.au/sites/default/files/documents/10_2014/review_of_the_research_report_2011_0.pdf.
Realmuto, G.M., & Azeem, M.W. (2008). Autistic disorder. In S.H. Fatemi, P.J. Clayton & N. Sartorius (Eds), The medical basis of psychiatry (3rd edn, pp. 355-373). New York: Humana.
Romanczyk, R.G., Gillis, J.M., White, S., & Digennaro, F. (2008). Comprehensive treatment packages for ASD: Perceived vs proven effectiveness. In J. Matson (Ed.), Clinical assessment and intervention for autism spectrum disorders (pp. 351-381). Amsterdam: Academic.
Weiss, M.J., Fiske, K., & Ferraioli, S. (2008). Evidence-based practice for autism spectrum disorders. In J. Matson (Ed.), Clinical assessment and intervention for autism spectrum disorders (pp. 33-63). Amsterdam: Academic.
Weitlauf, A.S., McPheeters, M.L., Peters, B., Sathe, N., Travis, R., Aiello, R., Williamson, E., Veenstra-VanderWeele, J., Krishnaswami, S., Jerome, R., & Warren, Z. (2014). Therapies for children with autism spectrum disorder: Behavioral interventions update. Comparative Effectiveness Review no. 137 [AHRQ Publication No. 14-EHC036-EF]. Rockville, MD: Agency for Healthcare Research and Quality. Retrieved 25 July 2016 from http://www.ncbi.nlm.nih.gov/books/NBK241444/.
Williams, K., Wray, J.A., & Wheeler, D.M. (2012). Intravenous secretin for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews 2012, 4, CD003495. doi: 10.1002/14651858.CD003495.pub3.
Wong, C., Odom, S.L., Hume, K., Cox, A.W., Fettig, A., Kucharczyk, S., Brock, M.E., Plavnick, J.B., Fleury, V.P., & Schultz, T.R. (2014). Evidence-based practices for children, youth, and young adults with autism spectrum disorder. Chapel Hill, NC: University of North Carolina, Frank Porter Graham Child Development Institute, Autism Evidence-Based Practice Review Group. Retrieved 25 July 2016 from http://fpg.unc.edu/sites/fpg.unc.edu/files/resources/reports-and-policy-briefs/2014-EBP-Report.pdf.